Comparative Effectiveness of Up To Three Lines of Chemotherapy Treatment Plans for Metastatic Colorectal Cancer
Modern chemotherapy agents transformed standard care for metastatic colorectal cancer (mCRC) but raised concerns about the financial burden of the disease. We studied comparative effectiveness of treatment plans that involve up to three lines of therapies and impact of treatment sequencing on health...
Main Authors: | Iakovos Toumazis PhD, Murat Kurt PhD, Artemis Toumazi MS, Loukia G. Karacosta PhD, Changhyun Kwon PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-08-01
|
Series: | MDM Policy & Practice |
Online Access: | https://doi.org/10.1177/2381468317729650 |
Similar Items
-
Network Meta-analysis of First-Line Systemic Treatment for Patients With Metastatic Colorectal Cancer
by: Shan Xu PhD, et al.
Published: (2021-09-01) -
Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy for Metastatic Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
by: Fei Lu MS, et al.
Published: (2021-05-01) -
Cost-Effectiveness Analysis of First-Line FOLFIRI Combined With Cetuximab or Bevacizumab in Patients With RAS Wild-Type Left-Sided Metastatic Colorectal Cancer
by: Jiaqi Han MD, et al.
Published: (2020-02-01) -
Targeting Colorectal Cancer Stem Cells as an Effective Treatment for Colorectal Cancer
by: Yu-Shui Ma PhD, et al.
Published: (2020-07-01) -
Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis
by: Yihong Liu MMed, et al.
Published: (2019-02-01)